• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Patients' rationale for declining participation in a cancer-associated weight loss study.患者拒绝参与癌症相关体重减轻研究的理由。
J Cachexia Sarcopenia Muscle. 2014 Jun;5(2):121-5. doi: 10.1007/s13539-014-0128-z. Epub 2014 Mar 13.
2
Patient/Caregiver influences for declining participation in supportive oncology trials.患者/照顾者拒绝参与支持性肿瘤学试验的影响因素。
J Support Oncol. 2008 Apr;6(4):168-74.
3
Patient recruitment to a randomized clinical trial of behavioral therapy for chronic heart failure.慢性心力衰竭行为疗法随机临床试验的患者招募
BMC Med Res Methodol. 2004 Apr 17;4:8. doi: 10.1186/1471-2288-4-8.
4
The Influence of Disease Perceptions on the Participation of Melanoma Patients and their Partners in Skin Self-Examination Education.疾病认知对黑色素瘤患者及其伴侣参与皮肤自我检查教育的影响。
J Community Med Health Educ. 2013 Nov 1;3(6):242. doi: 10.4172/2161-0711.1000242.
5
Health-related quality of life in early breast cancer.早期乳腺癌患者的健康相关生活质量
Dan Med Bull. 2010 Sep;57(9):B4184.
6
7
Exploring patients' reasons for declining contact in a cognitive behavioural therapy randomised controlled trial in primary care.探索初级保健认知行为治疗随机对照试验中患者拒绝联系的原因。
Br J Gen Pract. 2012 May;62(598):e371-7. doi: 10.3399/bjgp12X641492.
8
A qualitative study of factors influencing male participation in fertility research.一项影响男性参与生育力研究因素的定性研究。
Reprod Health. 2020 Nov 23;17(1):186. doi: 10.1186/s12978-020-01046-y.
9
Barriers to uptake among high-risk individuals declining participation in lung cancer screening: a mixed methods analysis of the UK Lung Cancer Screening (UKLS) trial.高危个体参与肺癌筛查意愿下降的阻碍因素:英国肺癌筛查(UKLS)试验的混合方法分析
BMJ Open. 2015 Jul 14;5(7):e008254. doi: 10.1136/bmjopen-2015-008254.
10
Why substitute decision makers provide or decline consent for ICU research studies: a questionnaire study.为什么替代决策人提供或拒绝同意 ICU 研究:一项问卷调查研究。
Intensive Care Med. 2012 Jan;38(1):47-54. doi: 10.1007/s00134-011-2411-1. Epub 2011 Nov 26.

引用本文的文献

1
Updates in Cancer Cachexia: Clinical Management and Pharmacologic Interventions.癌症恶病质的最新进展:临床管理与药物干预
Cancers (Basel). 2024 Apr 27;16(9):1696. doi: 10.3390/cancers16091696.
2
'Sick and tired': Patients reported reasons for not participating in clinical psychiatric research.“又病又累”:患者报告不参与临床精神科研究的原因。
Health Expect. 2021 May;24 Suppl 1(Suppl 1):20-29. doi: 10.1111/hex.12977. Epub 2019 Oct 11.
3
Hypermetabolism: should cancer types, pathological stages and races be considered in assessing metabolism and could elevated resting energy expenditure be the therapeutic target in patients with advanced cancer?高代谢:在评估代谢时是否应考虑癌症类型、病理分期和种族,静息能量消耗升高能否成为晚期癌症患者的治疗靶点?
J Cachexia Sarcopenia Muscle. 2015 Dec;6(4):391-2. doi: 10.1002/jcsm.12080. Epub 2015 Oct 27.
4
Diagnostic accuracy of three different MRI protocols in patients with inflammatory bowel disease.三种不同MRI方案对炎症性肠病患者的诊断准确性
Acta Radiol Open. 2015 Jun 11;4(6):2058460115588099. doi: 10.1177/2058460115588099. eCollection 2015 Jun.
5
The prognostic role of inflammation and hormones in patients with metastatic cancer with cachexia.炎症和激素在伴有恶病质的转移性癌症患者中的预后作用。
Med Oncol. 2015 Mar;32(3):56. doi: 10.1007/s12032-015-0497-y. Epub 2015 Feb 1.

本文引用的文献

1
Enrollment of patients with lung and colorectal cancers onto clinical trials.招募肺癌和结直肠癌患者参加临床试验。
J Oncol Pract. 2013 Mar;9(2):e40-7. doi: 10.1200/JOP.2012.000598.
2
Drivers and barriers to patient participation in RCTs.患者参与 RCT 的驱动因素和障碍。
Br J Cancer. 2013 Apr 16;108(7):1402-7. doi: 10.1038/bjc.2013.113. Epub 2013 Mar 19.
3
Does enrollment in cancer trials improve survival?癌症临床试验的参与是否能改善生存?
J Am Coll Surg. 2013 Apr;216(4):774-80; discussion 780-1. doi: 10.1016/j.jamcollsurg.2012.12.036. Epub 2013 Feb 13.
4
Facilitating enrollment in a Cancer Registry through modified consent procedures: a pilot study.通过修改同意程序促进癌症登记入组:一项试点研究。
J Empir Res Hum Res Ethics. 2012 Dec;7(5):71-5. doi: 10.1525/jer.2012.7.5.71.
5
Patient income level and cancer clinical trial participation.患者收入水平与癌症临床试验参与度。
J Clin Oncol. 2013 Feb 10;31(5):536-42. doi: 10.1200/JCO.2012.45.4553. Epub 2013 Jan 7.
6
Achieving high cancer control trial enrollment in the community setting: an analysis of the Community Clinical Oncology Program.在社区环境中实现高癌症控制试验的入组率:社区临床肿瘤学计划的分析。
Contemp Clin Trials. 2013 Mar;34(2):320-5. doi: 10.1016/j.cct.2012.12.008. Epub 2013 Jan 5.
7
Consent timing and experience: modifiable factors that may influence interest in clinical research.同意的时机和体验:可能影响对临床研究兴趣的可改变因素。
J Oncol Pract. 2012 Mar;8(2):91-6. doi: 10.1200/JOP.2011.000335. Epub 2011 Dec 6.
8
Barriers to therapeutic clinical trials enrollment: differences between African-American and white cancer patients identified at the time of eligibility assessment.治疗性临床试验入组障碍:在资格评估时确定的非裔美国人和白人癌症患者之间的差异。
Clin Trials. 2012 Dec;9(6):788-97. doi: 10.1177/1740774512458992. Epub 2012 Oct 2.
9
Assessing an intervention to improve clinical trial perceptions among predominately African-American communities in South Carolina.评估一项旨在改善南卡罗来纳州以非裔美国人为主的社区对临床试验看法的干预措施。
Prog Community Health Partnersh. 2012 Fall;6(3):249-63. doi: 10.1353/cpr.2012.0038.
10
Participation in adjuvant clinical breast cancer trials: does study participation improve survival compared to guideline adherent adjuvant treatment? A retrospective multi-centre cohort study of 9,433 patients.参与辅助临床乳腺癌试验:与遵循指南的辅助治疗相比,研究参与是否能改善生存?一项对 9433 例患者的回顾性多中心队列研究。
Eur J Cancer. 2013 Feb;49(3):553-63. doi: 10.1016/j.ejca.2012.08.011. Epub 2012 Sep 6.

患者拒绝参与癌症相关体重减轻研究的理由。

Patients' rationale for declining participation in a cancer-associated weight loss study.

机构信息

Cancer Education Center, Mayo Clinic Cancer Center, Rochester, MN, USA.

出版信息

J Cachexia Sarcopenia Muscle. 2014 Jun;5(2):121-5. doi: 10.1007/s13539-014-0128-z. Epub 2014 Mar 13.

DOI:10.1007/s13539-014-0128-z
PMID:24622952
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4053567/
Abstract

BACKGROUND

Fewer than 5 % of cancer patients participate in clinical research. Although this paltry rate has led to extensive research on this topic, previous studies have not sought verbatim comments in a real-time, comprehensive manner to understand why patients decline.

METHODS

This study used a low-risk, non-interventional parent study that focused on cancer-associated weight loss to understand patients' reasons for declining research participation. A research assistant wrote down the name and verbatim reason of all patients who declined to participate. These comments with accompanying patient demographic data are the subject of this report.

RESULTS

Of the 334 patients, 51 (15 %) declined parent study enrollment; three comment-related themes emerged: (1) a repelling sense of too much institutional research, (2) overwhelming personal health issues, and (3) a low likelihood of returning to the institution. In univariate and multivariate analyses, only age (older) and gender (female) were associated with non-enrollment. Interestingly, 41 patients with fatigue scores of 7 or worse and 26 with pain scores of 7 or worse were enrolled.

CONCLUSIONS

Although many factors were associated with declining to participate in research, symptom severity was not. Upfront education might help cancer patients better prioritize their participation in research, particularly as some patients felt overwhelmed by too much research in the institution; and for now, investigators should continue to keep asking patients for their participation.

摘要

背景

参与临床研究的癌症患者不足 5%。尽管这一低比例导致了对此问题的广泛研究,但之前的研究并未以实时、全面的方式寻求逐字评论,以了解患者拒绝的原因。

方法

本研究使用了一项低风险、非干预性的母研究,该研究专注于癌症相关体重减轻,以了解患者拒绝参与研究的原因。一名研究助理记下了所有拒绝参与的患者的姓名和逐字原因。这些评论以及伴随的患者人口统计学数据是本报告的主题。

结果

在 334 名患者中,有 51 名(15%)拒绝了母研究的入组;三个评论相关主题出现:(1)对过多机构研究的排斥感,(2)个人健康问题的压倒性,(3)返回机构的可能性低。在单变量和多变量分析中,仅年龄(较大)和性别(女性)与未入组相关。有趣的是,41 名疲劳评分 7 或更高的患者和 26 名疼痛评分 7 或更高的患者被入组。

结论

尽管许多因素与拒绝参与研究有关,但症状严重程度并非如此。预先教育可能有助于癌症患者更好地优先考虑参与研究,特别是因为一些患者感到机构内的研究过多而不堪重负;目前,研究人员应继续征求患者的参与意愿。